Ensysce Biosciences, Inc. short interest in 2026
In 2026, Ensysce Biosciences, Inc.'s disclosed short interest ran from 5.79% of shares outstanding on 15 Jan 2026 to 6.20% on 15 Sep 2026, a change of +0.41 percentage points. The year's high was 9.22% on 27 Feb 2026 and its low 1.24% on 30 Jun 2026, averaging 4.57% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.93 days on 15 Jan 2026. Full history: Ensysce Biosciences, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 5.79% (15 Jan 2026)
- End of year
- 6.20% (15 Sep 2026)
- Change
- +0.41 pp
- High
- 9.22% (27 Feb 2026)
- Low
- 1.24% (30 Jun 2026)
- Average
- 4.57%
- Highest days to cover
- 1.93 (15 Jan 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 5.79% | 1.93 | |
| 30 Jan 2026 | 5.68% | 1.76 | |
| 13 Feb 2026 | 4.78% | 1.00 | |
| 27 Feb 2026 | 9.22% | 1.00 | |
| 13 Mar 2026 | 3.75% | 1.00 | |
| 31 Mar 2026 | 2.10% | 1.00 | 10-K filed, results (8-K) |
| 15 May 2026 | 5.54% | 1.00 | 10-Q filed, results (8-K) |
| 15 Jun 2026 | 2.48% | 1.00 | |
| 30 Jun 2026 | 1.24% | 1.00 | |
| 15 Jul 2026 | 2.74% | 1.00 | |
| 31 Jul 2026 | 1.30% | 1.00 | |
| 14 Aug 2026 | 5.86% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 7.33% | 1.16 | |
| 15 Sep 2026 | 6.20% | 1.75 |
See also: Ensysce Biosciences, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.